Kejintaiji New Technology key facts
as of Oct 2026- Developer and manufacturer of high-energy medical radiation equipment designed for therapeutic and diagnostic applications.
- Kejintaiji New Technology is valued at approximately $57.2M as of Oct 2026 (last reported valuation).
- It has raised $52.3M; the latest was Later Stage VC ($52.3M) in Oct 2025.
- Notable investors include CAS Star, Chinese Academy of Sciences Holdings, Lanzhou Foci Pharmaceutical.
- Status: Privately Held (backing).
Kejintaiji New Technology's last reported valuation, Oct 2025. Nothing priced has surfaced since.
- ·Watch Kejintaiji New Technology: the Monday email on marks, rounds and moves
Kejintaiji New Technology funding rounds
No funding rounds for Kejintaiji New Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Kejintaiji New Technology
3Kejintaiji New Technology valuation
Kejintaiji New Technology's last reported valuation was $57.2 million in Oct 2025. No priced round, secondary trade or fund mark has surfaced since.
Kejintaiji New Technology investors
3 investors are on record for Kejintaiji New Technology, including CAS Star, Chinese Academy of Sciences Holdings and Lanzhou Foci Pharmaceutical.
About Kejintaiji New Technology
Developer and manufacturer of high-energy medical radiation equipment designed for therapeutic and diagnostic applications. The company provides custom electromagnetic and vacuum systems, enabling medical industry and research users with precision engineering and advanced material solutions.
- Sector
- Healthcare
- HQ
- Lanzhou, China
- Founded
- 2002
- Website
- kjtjgs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.